US Patent US8691295
Patented to Support Vascular Health
Read Excerpts from the Patent"The supplement was developed to assist in the management of major cardiovascular maladies."
"A major problem addressed by the supplement is the management and control of hypertension."
"The supplement's ingredients are documented to have positive effects on lowering systemic blood pressure by having a vasodilatation effect on the peripheral vasculature much like hydralazine; causing relaxation of smooth muscles.
"The supplement achieves [vasodilatation] through its active ingredients L-arginine and L-citulline which are direct precursors in the synthesis of nitric oxide.
"[The supplement] plays a central role in endothelial angiogenesis via a cascade enzymatic sequence resulting in a potent vasodilatation effect."
"Aside from this, arginine and citulline also act via the nitric oxide reaction as a significant mechanism for endothelial cell repair, a benefit not commonly found in any prescribed medication."
Read the patent for yourself.